eLaws | eCases | Florida State | Florida Courts | Counties & Cities of Florida | Code of Federal Regulations |
Home » 2009 Issues » Vol. 35, No. 43 (10/30/2009) » The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list.

  The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list.  


  • DEPARTMENT OF HEALTH
    Board of Pharmacy
    RULE NO: RULE TITLE
    64B16-27.500: Negative Drug Formulary
    PURPOSE AND EFFECT: The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list.
    SUBJECT AREA TO BE ADDRESSED: Negative Drug Formulary
    SPECIFIC AUTHORITY: 465.005, 465.025(6) FS., Ch. 2001-146, Laws of Florida.
    LAW IMPLEMENTED: 465.025(6) FS., Ch. 2001-146, Laws of Florida.
    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE WEEKLY.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Rebecca Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS NOT AVAILABLE.
Leave a Comment

Document Information

Subject:
Negative Drug Formulary
Purpose:
The Board proposes the rule amendment to consider whether levothyroxine sodium should remain on the negative formulary list.
Rulemaking Authority:
465.005, 465.025(6) FS., Ch. 2001-146, Laws of Florida.
Law:
465.025(6) FS., Ch. 2001-146, Laws of Florida.
Contact:
Rebecca Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254
Related Rules: (1)
64B16-27.500. Negative Drug Formulary